Analysts’ Upgrades for June 2nd (BKHYY, BPMUF, CADL, CNI, CRDF, DELL, DPSI, DSP, EDU, EMX)

Analysts’ upgrades for Thursday, June 2nd:

Bank Hapoalim B.M. (OTCMKTS:BKHYY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Bank Hapoalim B.M. offers banking, financial products and services primarily in Israel and internationally, through its subsidiaries. Its operating segment consists of Households, Private Banking, Small Business, Commercial, Corporate and Financial Management. The company offers current-account management services, deposits and saving plans, credit cards, capital-market and housing loans products and services, investment products, check discounting, foreign currency, foreign trade and other financing transactions services. It also provides factoring services which consist of financial and strategic consulting for mergers and acquisitions, privatization processes, public and private issues, guidance of companies, consulting, underwriting and management services, brokerage services, research, custody and other related services. Bank Hapoalim B.M. is based in Tel Aviv, Israel. “

Basilea Pharmaceutica (OTCMKTS:BPMUF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company developing products that address the medical challenge of increasing resistance and non-response to current treatment options in the therapeutic areas of bacterial infections, fungal infections and cancer. With two commercialized drugs, the company is committed to discovering, developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions. “

Candel Therapeutics (NASDAQ:CADL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Candel Therapeutics Inc. is a late clinical stage biopharmaceutical company. It involved in developing novel oncolytic viral immunotherapies. The company’s product pipeline includes CAN-2409 and CAN-3110. Candel Therapeutics Inc. is based in NEEDHAM, Mass. “

Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded by analysts at CIBC from a neutral rating to an outperform rating.

Cardiff Oncology (NASDAQ:CRDF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Cardiff Oncology Inc. is a clinical-stage biotechnology company. It engages in developing treatment for cancer patients. The company’s product pipeline consists of a Phase 1b/2 study of onvansertib in combination with FOLFIRI/Avastin(R) in KRAS-mutated metastatic colorectal cancer; a Phase 2 study of onvansertib in combination with Zytiga(R) in Zytiga-resistant metastatic castration-resistant prostate cancer; and a Phase 2 study of onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. Cardiff Oncology Inc., formerly known as Trovagene Inc., is based in SAN DIEGO. “

Dell Technologies (NYSE:DELL) was upgraded by analysts at Zacks Investment Research from a sell rating to a buy rating. They currently have $57.00 price target on the stock. According to Zacks, “Dell Technologies Inc. is a provider of information technology solutions. The company’s operating segment consists of Client Solutions, Enterprise Solutions Group and Dell Software Group. Client Solutions segment includes sales to commercial and consumer customers of desktops, thin client products, notebooks as well as services and third-party software and peripherals of Client Solutions hardware. ESG segment includes servers, networking and storage as well as services and third-party software and peripherals of ESG hardware. DSG segment includes systems management, security software solutions and information management software offerings. Dell Technologies Inc. is headquartered in Round Rock, Texas. “

Decisionpoint Systems (OTCMKTS:DPSI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “DecisionPoint Systems, Inc. is engaged in providing enterprise mobility and radio frequency identification technologies. It sells and installs mobile devices, software, and related bar coding equipment. The company makes enterprise software applications accessible to the front-line workers. DecisionPoint offers business process and mobile solution consulting; technology implementation and support; Hardware and software and consumables. DecisionPoint Systems, Inc., formerly known as Comamtech, Inc., is headquartered in Foothill Ranch, California. “

Viant Technology (NASDAQ:DSP) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Viant Technology Inc. is an advertising software company which enables marketers and their advertising agencies to plan, buy and measure their advertising. Its self-service DSP for omnichannel advertising, Adelphic(R), provides execute programmatic advertising campaigns across desktop, mobile, connected TV, linear TV, streaming audio and digital billboards. Viant Technology Inc. is based in IRVINE, Calif. “

New Oriental Education & Technology Group (NYSE:EDU) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “New Oriental is the largest provider of private educational services in China based on the number of program offerings, total student enrollments and geographic presence. New Oriental offers a wide range of educational programs, services and products consisting primarily of English and other foreign language training, test preparation courses for major admissions and assessment tests in the United States, the PRC and Commonwealth countries, primary and secondary school education, development and distribution of educational content, software and other technology, and online education. New Oriental’s ADSs, each of which represents four common shares, currently trade on the New York Stock Exchange under the symbol ”EDU.” “

EMX Royalty (NYSEAMERICAN:EMX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $2.25 target price on the stock. According to Zacks, “EMX Royalty Corporation, together with its subsidiaries, operates as a royalty and prospect generator engaged in the exploring for, and generating royalties from, metals and minerals properties. The Company¬ís royalty and exploration portfolio mainly consists of properties in North America, Turkey, Europe, Haiti, Australia, and New Zealand. “

Enjoy Technology (NASDAQ:ENJY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Enjoy Technology Inc. is a technology-powered platform reinventing Commerce at Home to store directly to the customer. Enjoy Technology Inc., formerly known as Marquee Raine Acquisition Corp., is headquarted in PALO ALTO, Calif. “

Esquire Financial (NASDAQ:ESQ) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $43.00 price target on the stock. According to Zacks, “Esquire Financial Holdings, Inc. is a bank holding company. It provides banking products and services to law professionals, professional service firms, small to mid-sized businesses and individuals primarily in the United States. The company operates primarily in Garden City, New York; Palm Beach Gardens and Florida. Esquire Financial Holdings, Inc. is headquartered in Jericho, New York. “

SouthState (NASDAQ:SSB) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating.

Want More Great Investing Ideas?

Receive News & Ratings for Bank Hapoalim BM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bank Hapoalim BM and related companies with MarketBeat.com's FREE daily email newsletter.